NO136251C - Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater. - Google Patents
Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater.Info
- Publication number
- NO136251C NO136251C NO1533/72A NO153372A NO136251C NO 136251 C NO136251 C NO 136251C NO 1533/72 A NO1533/72 A NO 1533/72A NO 153372 A NO153372 A NO 153372A NO 136251 C NO136251 C NO 136251C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutically active
- pyridazine derivatives
- analogical procedure
- active pyridazine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH695271A CH547808A (de) | 1971-05-11 | 1971-05-11 | Verfahren zur herstellung neuer cycloalkan(c)pyridazine. |
| CH695171A CH547807A (de) | 1971-05-11 | 1971-05-11 | Verfahren zur herstellung neuer cycloalkan(c)pyridazine. |
| CH768371A CH547814A (de) | 1971-05-26 | 1971-05-26 | Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine. |
| CH767971A CH547813A (de) | 1971-05-26 | 1971-05-26 | Verfahren zur herstellung neuer pyrido (4,3-c)pyridazine. |
| CH784971A CH553201A (de) | 1971-05-26 | 1971-05-28 | Verfahren zur herstellung neuer pyrido (4,3-c)pyridazinderivate. |
| CH784871A CH551433A (de) | 1971-05-26 | 1971-05-28 | Verfahren zur herstellung neuer 3-hydrazino-5,6,7,8-tetrahydropyrido (4,3-c)pyridazin-derivate. |
| CH1512071A CH555350A (de) | 1971-05-26 | 1971-10-15 | Verfahren zur herstellung neuer 3-hydrazinopyrido(4,3c)-pyridazine. |
| CH1512171A CH555841A (de) | 1971-05-26 | 1971-10-15 | Verfahren zur herstellung neuer 3-hydrazinopyrido-(4,3c)pyridazine. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO136251B NO136251B (xx) | 1977-05-02 |
| NO136251C true NO136251C (no) | 1977-08-10 |
Family
ID=27570368
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO1533/72A NO136251C (no) | 1971-05-11 | 1972-05-02 | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US3838125A (xx) |
| JP (1) | JPS5750791B1 (xx) |
| AU (1) | AU472726B2 (xx) |
| BE (1) | BE783219A (xx) |
| CA (1) | CA943542A (xx) |
| DD (1) | DD97418A5 (xx) |
| DK (1) | DK139625B (xx) |
| FI (1) | FI55343C (xx) |
| GB (2) | GB1392474A (xx) |
| HU (1) | HU168682B (xx) |
| IE (1) | IE36710B1 (xx) |
| IL (1) | IL39392A (xx) |
| NL (1) | NL176565C (xx) |
| NO (1) | NO136251C (xx) |
| PL (1) | PL81827B1 (xx) |
| SE (1) | SE400557B (xx) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI55343C (fi) * | 1971-05-11 | 1979-07-10 | Sandoz Ag | Foerfarande foer framstaellning av nya, blodtryckssaenkande 3-hydrazinopyrido(4,3-c)pyridazinderivat |
| FI224574A (xx) * | 1973-08-02 | 1975-02-03 | Sandoz Ag | |
| SE418800B (sv) * | 1975-11-13 | 1981-06-29 | Sandoz Ag | Forfarande for framstellning av nya antihypertensiva preparat |
| US4277472A (en) * | 1978-11-10 | 1981-07-07 | Byk Gulden Lomberg Chemische Fabrik Gmbh | 3,6-Disubstituted-5,7-(lower alkano)-5,6,7,8-tetrahydropyrido(4,3-C)pyridazines; their intermediates, preparation, antihypertensive use and compositions |
| US4473574A (en) * | 1982-02-01 | 1984-09-25 | Sandoz Ltd. | Prophylaxis of arterial disease |
| US6705323B1 (en) | 1995-06-07 | 2004-03-16 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and methods |
| US6176240B1 (en) | 1995-06-07 | 2001-01-23 | Conceptus, Inc. | Contraceptive transcervical fallopian tube occlusion devices and their delivery |
| TW432073B (en) * | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| US6821974B2 (en) * | 2002-03-05 | 2004-11-23 | Barbeau Pharma, Inc | Stable pharmaceutical compositions |
| US6825196B2 (en) * | 2002-03-05 | 2004-11-30 | Barbeau Pharma, Inc. | Stable pharmaceutical compositions |
| CN102911173A (zh) * | 2012-11-08 | 2013-02-06 | 苏州施亚生物科技有限公司 | 5,6,7,8-四氢-2H-吡啶并[4,3-c]哒嗪-3-酮的合成方法 |
| CN106905315B (zh) * | 2017-03-02 | 2019-09-27 | 北京工业大学 | 四氢吡啶并[3,4-d]嘧啶类化合物及其制备方法和应用 |
| WO2020012916A1 (ja) | 2018-07-10 | 2020-01-16 | 国立研究開発法人産業技術総合研究所 | 積層構造体及びその製造方法並びに半導体デバイス |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI55343C (fi) * | 1971-05-11 | 1979-07-10 | Sandoz Ag | Foerfarande foer framstaellning av nya, blodtryckssaenkande 3-hydrazinopyrido(4,3-c)pyridazinderivat |
-
1972
- 1972-05-02 FI FI1245/72A patent/FI55343C/fi active
- 1972-05-02 SE SE7205731A patent/SE400557B/xx unknown
- 1972-05-02 DK DK217572AA patent/DK139625B/da not_active IP Right Cessation
- 1972-05-02 NO NO1533/72A patent/NO136251C/no unknown
- 1972-05-05 GB GB2106072A patent/GB1392474A/en not_active Expired
- 1972-05-05 GB GB4572274A patent/GB1392475A/en not_active Expired
- 1972-05-08 US US00251035A patent/US3838125A/en not_active Expired - Lifetime
- 1972-05-09 BE BE783219A patent/BE783219A/xx not_active IP Right Cessation
- 1972-05-09 IL IL39392A patent/IL39392A/en unknown
- 1972-05-09 PL PL1972155270A patent/PL81827B1/pl unknown
- 1972-05-09 DD DD162838A patent/DD97418A5/xx unknown
- 1972-05-09 HU HUSA2354A patent/HU168682B/hu unknown
- 1972-05-09 IE IE617/72A patent/IE36710B1/xx unknown
- 1972-05-10 AU AU42135/72A patent/AU472726B2/en not_active Expired
- 1972-05-10 CA CA141,760A patent/CA943542A/en not_active Expired
- 1972-05-10 JP JP47046266A patent/JPS5750791B1/ja active Pending
- 1972-05-12 NL NLAANVRAGE7206477,A patent/NL176565C/xx not_active IP Right Cessation
-
1979
- 1979-04-13 US US06/029,892 patent/US4478837A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| NL176565C (nl) | 1985-05-01 |
| NL7206477A (xx) | 1972-11-14 |
| JPS5750791B1 (xx) | 1982-10-28 |
| DK139625B (da) | 1979-03-19 |
| BE783219A (fr) | 1972-11-09 |
| IL39392A0 (en) | 1972-07-26 |
| FI55343C (fi) | 1979-07-10 |
| US3838125A (en) | 1974-09-24 |
| GB1392475A (en) | 1975-04-30 |
| FI55343B (fi) | 1979-03-30 |
| IE36710B1 (en) | 1977-02-02 |
| IE36710L (en) | 1972-11-11 |
| HU168682B (xx) | 1976-06-28 |
| CA943542A (en) | 1974-03-12 |
| DD97418A5 (xx) | 1973-05-05 |
| AU472726B2 (en) | 1976-06-03 |
| PL81827B1 (xx) | 1975-10-31 |
| DK139625C (xx) | 1979-09-03 |
| NO136251B (xx) | 1977-05-02 |
| AU4213572A (en) | 1973-11-15 |
| GB1392474A (en) | 1975-04-30 |
| US4478837A (en) | 1984-10-23 |
| IL39392A (en) | 1977-10-31 |
| NL176565B (nl) | 1984-12-03 |
| SE400557B (sv) | 1978-04-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO136837C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pleuromutiliner | |
| NO138805C (no) | Analogifremgangsmaate for fremstilling av farmakologisk aktive triazolforbindelser | |
| NO140301C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo(5,1-f)-as-triaziner | |
| NO136793C (no) | Analogifremgangsm}te til fremstilling av terapeutisk virksomme substituerte 1,2,4-triazolderivater. | |
| NO136298C (no) | Analogifremgangsm}te til fremstilling av antibakterielt virksomme imidazolderivater | |
| NO136045C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazinoner. | |
| NO136094C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive d-1-(4-amino-fenyl)-2-alkylamino-etanol-derivater. | |
| NO138565C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater | |
| NO137694C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner | |
| NO136251C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyridazin-derivater. | |
| NO139685C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive isoindolin-derivater | |
| NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
| NO773495L (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylalkylaminer | |
| NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
| SE400551B (sv) | Forfarande for framstellning av terapeutiskt aktiva 3-amino-5-karbamylbensoesyraderivat | |
| NO136574C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive pyrimidinderivater. | |
| NO136926C (no) | Analogifremgangsm}te til fremstilling av terapeutisk aktive papaverinanaloger | |
| NO136795C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive indoliner | |
| NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
| NO137696C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepin-derivater | |
| NO136841C (no) | Analogifremgangsm}te for fremstilling av terapeutisk aktive fenylimidazolidinoner | |
| NO137727C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener | |
| NO137695C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser | |
| NO136198C (no) | Analogifremgangsm}te ved fremstilling av terapeutisk aktivt 16-carboxy-17-methoxy-eburnan. | |
| NO136977C (no) | Analogifremgangsm}te for mstilling av terapeutisk aktive oksazolidiner |